Associate Professor of Radiation and Cellular Oncology, University of Chicago Medicine
Radiation Oncology
Doctor Stanley L. Liauw, MD practices Radiation Oncology. He graduated from University of Texas Southwestern Medical School. He has 12 awards "CMS Meaningful Use Stage 1 Certification", "Department of Radiation and Cellular Oncology, Samuel Hellman Outstanding Teacher of the Year Award", "Teacher of the Year Award", "Seattle Prostate Institute Fellowship", "Research and Education Foundation, Roentgen Resident/Fellow Research Award", "Young Oncologist Award", "Research Trainee Prize", "Outstanding Resident Teaching Award", "Phi Beta Kappa (Top 5% of graduating class)", "Sigma Xi, National Scientific Research Society", "Academic Scholarship" and "Tau Beta Pi, National Engineering Honor Society". Dr. Stanley L. Liauw is also published. He has 57 publications published. The lastest publication: "Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancer.' Stanley L. Liauw, MD is registered with Medicare.
Publications
- Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancer.
- Management of Low-Stage Testicular Seminoma.
- The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer.
- Image-guided radiation therapy for prostate cancer: A computed tomography-based assessment of fiducial marker migration between placement and 7 days.
- High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men...
- Late toxicity and quality of life after definitive treatment of prostate cancer: redefining optimal rectal sparing constraints for intensity-modulated radiation therapy.
- Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
- Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity.
- Toxicity After External Beam Radiotherapy for Prostate Cancer: An Analysis of Late Morbidity in Men With Diabetes Mellitus.
- Validation of normal tissue complication probability predictions in individual patient: late rectal toxicity.
- Effects of aspirin on cancer initiation and progression.
- Evaluation of the Prostate Bed for Local Recurrence After Radical Prostatectomy Using Endorectal Magnetic Resonance Imaging.
- New paradigms and future challenges in radiation oncology: an update of biological targets and technology.
- Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
- Prostate-specific antigen halving time while on neoadjuvant androgen deprivation therapy is associated with biochemical control in men treated with radiation therapy f...
- Late Toxicity After Intensity-Modulated Radiation Therapy for Localized Prostate Cancer: An Exploration of Dose-Volume Histogram Parameters to Limit Genitourinary and ...
- A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.
- Prolongation of Total Treatment Time Because of Infrequently Missed Days of Treatment is Not Associated With Inferior Biochemical Outcome After Dose-Escalated Radiatio...
- External Beam Radiotherapy for Prostate Cancer: Urinary Outcomes for Men with High International Prostate Symptom Scores (IPSS).
- External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity.
- Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
- Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.
- Late rectal toxicity after prostate brachytherapy: influence of supplemental external beam radiation on dose-volume histogram analysis.
- Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis.
- The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy.
- External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?
- Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores.
- A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
- Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?
- Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
- The use of capecitabine in the combined-modality therapy for rectal cancer.
- Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection?
- Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
- Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck.
- The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patients.
- Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
- Radiotherapy after subtotally resected or recurrent ganglioglioma.
- Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation.
- Definitive radiotherapy for head-and-neck cancer with radiographically positive retropharyngeal nodes: incomplete radiographic response does not necessarily indicate f...
- Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
- Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck.
- The effect of intravenous contrast on intensity-modulated radiation therapy dose calculations for head and neck cancer.
- Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
- Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease.
- Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience.
- Herpes zoster and radiation therapy: What radiation oncologists need to know about diagnosing, preventing, and treating herpes zoster.
- Radiotherapeutic strategies in the management of low-risk prostate cancer.
- The role of radiotherapy in locally advanced pancreatic carcinoma.
- Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?
- Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry.
- Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer.
- Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality of life.
- Quality of Life after Post-Prostatectomy Intensity Modulated Radiation Therapy: Pelvic Nodal Irradiation Is Not Associated with Worse Bladder, Bowel, or Sexual Outcomes.
- Considering the role of radiation therapy for gastrointestinal stromal tumor.
- Clinical outcomes for gastric cancer following adjuvant chemoradiation utilizing intensity modulated versus three-dimensional conformal radiotherapy.
- Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy.
Schools
University of Texas Southwestern Medical Center At Dallas
Brigham and Women39s Hospital
Shands Healthcare
Doctors Specialties
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Department of Radiation and Cellular Oncology, Samuel Hellman Outstanding Teacher of the Year Award
- Teacher of the Year Award
- Seattle Prostate Institute Fellowship
- Research and Education Foundation, Roentgen Resident/Fellow Research Award
- Young Oncologist Award
- Research Trainee Prize
- Outstanding Resident Teaching Award
- Phi Beta Kappa (Top 5% of graduating class)
- Sigma Xi, National Scientific Research Society
- Academic Scholarship
- Tau Beta Pi, National Engineering Honor Society
Education
-
University of Florida
-
Brigham and Women's Hospital
-
University of Texas Southwestern Medical School
Hospital
-
University of Chicago Medical Center
-
University of Illinois Hospital & Health Sciences System
-
Jesse Brown Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER |
|
1922011790 |
| NPPES Provider LastName |
|
LIAUW |
| NPPES Provider FirstName |
|
STANLEY |
| NPPES Provider ZIPCode |
|
606371426 |
| NPPES Provider State |
|
IL |
| Specialty Description |
|
Radiation Oncology |
| Total Claim Count |
|
282.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1922011790 |
| Last Name Of The Provider |
LIAUW |
| First Name Of The Provider |
STANLEY |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
